Details of the Drug

General Information of Drug (ID: DMNH84A)

Drug Name

Anti-CD3 activated vaccine-primed lymphocytes

Synonyms

VPLN tumor vaccine, University of Michigan; Anti-CD3 activated vaccine-primed lymphocytes (cancer); Monoclonal antiobody activated vaccine-primed lymphocytes (cancer), University of Michigan; Vaccine-primed lymph node (VPLN) cells, University of Michigan; Anti-CD3 activated vaccine-primed lymphocytes (cancer), University of Michigan; Anti-CD3/anti-CD28 activated vaccine-primed lymphocytes (cancer), University of Michigan

Indication

Disease Entry	ICD 11	Status	REF
Melanoma	2C30	Phase 2	[1]
------------------------------------------------------------------------------------

Cross-matching ID

TTD ID: D0E8KO

References

1	Phase II trial of autologous tumor vaccination, anti-CD3-activated vaccine-primed lymphocytes, and interleukin-2 in stage IV renal cell cancer. J Clin Oncol. 2003 Mar 1;21(5):884-90.